Collegium Pharmaceutical, Inc. (COLL) vs Ironwood Pharmaceuticals, Inc. (IRWD)
- Collegium Pharmaceutical, Inc. COLL 23.19 +0.04%
- Ironwood Pharmaceuticals, Inc. IRWD 3.50 −7.16%
Collegium Pharmaceutical, Inc. and Ironwood Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $754.6M against $623.0M — 1.2× the size. Ironwood Pharmaceuticals, Inc. trades at the lower P/E: 4.4× against 15.2×. Ironwood Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 26.2% against 14.3%. Ironwood Pharmaceuticals, Inc. has the higher net margin (33.4% vs 5.93%) and the higher return on invested capital (101.6% vs 7.85%). Across the 20 metrics below, Ironwood Pharmaceuticals, Inc. leads on 13 and Collegium Pharmaceutical, Inc. on 7.
Valuation
Profitability
| Metric | COLL | IRWD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.02% | 100.00% | 53.94% |
| Operating margin | 19.48% | 60.15% | 0.00% |
| Net margin | 5.93% | 33.36% | 0.00% |
| Free cash flow margin | 40.62% | 47.66% | 0.00% |
| Return on equity | 17.61% | (55.26%) | (0.40%) |
| Return on assets | 2.57% | 41.35% | (3.32%) |
| Return on invested capital | 7.85% | 101.61% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack